Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismEGFR T790M inhibitors [+1] |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Not yet recruitingPhase 4IIT A multi-center, prospective, post-marketing "real world" clinical study on the efficacy and safety of rhPro-UK in the treatment of acute ischemic stroke (treatment within 4.5 hours of onset)
/ Not yet recruitingNot ApplicableIIT Effect of remifentanil combined with remimazolam on hypotension after induction of anesthesia in elderly patients: a randomized single-blind controlled trial
/ Not yet recruitingNot ApplicableIIT Acute Ischemic Stroke Reperfusion Therapy - Recombinant Human TNK Tissue-type Plasminogen Activator for Injection (rhTNK-tPA, Mingfule) Real-World Data Monitoring Registry Study for Intravenous Thrombolysis
100 Clinical Results associated with Linyi People’s Hospital
0 Patents (Medical) associated with Linyi People’s Hospital
100 Deals associated with Linyi People’s Hospital
100 Translational Medicine associated with Linyi People’s Hospital